Interestingly, the mouse neoplasms that expressed ARF-BP1 at high levels derived from near opposite ends of the mature B cell developmental spectrum in mice including DBLL that derive from pre-germinal center (pre-GC) B cells to PCT, which originate from mature plasma cells. The gene discussed is CDKN2A; the disease is neoplasm.